Stories about Krankenversicherung

Subscribe to Krankenversicherung

20.08.2020 – 16:21

Jennewein Biotechnologie GmbH
US Customs rules in favor of Jennewein Biotechnologie regarding importation of 2'-Fucosyllactose

RHEINBREITBACH, Germany (ots) - Jennewein Biotechnologie GmbH the leading manufacturer of human milk oligosaccharides (HMOs) in the world, announced today that the Intellectual Property Rights Branch, Regulations and Rulings, U.S. Customs and Border Protection issued a Ruling Letter which asserts that the HMO 2'-fucosyllactose (2'-FL) being produced by Jennewein ...

more
29.07.2020 – 15:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie GmbH announces the foundation of Jennewein Biotech Corp. USA

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, a market leading and science-based company for developing and producing human milk oligosaccharides (HMOs) and rare monosaccharides, announced today that it has established its subsidiary in the USA. Jennewein Biotech USA Corporation, a Delaware Corporation, utilizing warehouses in Chicago, IL and Columbus, OH, will ...

more
27.05.2020 – 11:00

Jennewein Biotechnologie GmbH
Jennewein publishes new results on the norovirus-inhibiting effect of complex oligosaccharides

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH today announces the publication of the latest results from its norovirus research program in the Journal of Biotechnology. Breast-fed infants are less likely than bottle-fed infants to contract norovirus infections, and earlier work has indicated a link between this protective effect and human milk oligosaccharides ...

more
20.05.2020 – 15:09

Jennewein Biotechnologie GmbH
Supply of Key Ingredient in advanced infant formula by Jennewein is secured

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, a worldwide leading manufacturer of human milk oligosaccharides (HMOs) announces today that the U.S. International Trade Commission (ITC) issued on May 19, 2020 a Final Determination finding that one of Jennewein's advanced bacterial production strains for producing 2'-fucosyllactose (2'-FL) does not infringe ...

more
10.01.2020 – 12:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie GmbH enforces its patents in the field of human milk oligosaccharides against Nestlé in Germany

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH filed a patent infringement suit with the regional court in Mannheim on January 09, 2020 against Nestlé Nutrition GmbH and its holding company Nestlé Deutschland AG. Nestlé offers its infant formula Beba Supreme which contains two human milk oligosaccharides - ...

more
08.01.2020 – 17:00

Jennewein Biotechnologie GmbH
Publication of a toxicological study: a milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-mix

Rheinbreitbach (ots) - Jennewein Biotechnology announces another milestone in the Worldwide approval of a new product generation, the "HMO-Mix". The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats", was recently accepted for publication by the ...

more
04.12.2019 – 09:01

ForaCare Suisse AG
ForaCare Suisse AG Launches "Lab in the Pocket" Technology

ST. GALLEN, Switzerland (ots) - Innovative FORA 6 GTel Capability Provides 6 Tests with Single Device, SIM Direct-to-Telehealth Connectivity ForaCare Suisse AG announced the launch of its FORA 6 GTel multi-functional monitoring device with its new "Lab in the Pocket" technology (available on the GTel model and FORA 6 Series products). The innovative 6-in-1 monitoring technology provides seamless 3G/4G data transmission of ...

more
25.11.2019 – 10:13

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie obtains US-FDA GRAS status on alternative 2'-fucosyllactose fermentation strain

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, Rheinbreitbach, the leading manufacturer of human milk oligosaccharides (HMOs), announces that the U.S. Food and Drug Administration (FDA) issued a "no question" response letter to Jennewein's supplement of its GRAS Notice GRN571, thereby acknowledging that the ...

more
25.11.2019 – 10:02

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie sues Glycom for patent infringement in Denmark

Rheinbreitbach (ots) - Jennewein Biotechnologie develops fermentative processes for manufacturing of human milk oligosaccharides (HMOs) cost efficiently in an industrial scale since 2005 to make these special sugars available for affordably priced infant formula and other uses in food. Jennewein Biotechnologie was the first commercial vendor of HMOs, and brought the ...

more
03.11.2019 – 12:30

ClinicAll

2
ClinicAll enters cooperation partnership with The Private Office of Sheikh Saeed Bin Ahmed Al Maktoum and SEED Group

more
11.09.2019 – 17:00

Jennewein Biotechnologie GmbH
Administrative Law Judge issues ruling in patent dispute concerning 2'-FL production and beta-galactosidase activity

Rheinbreitbach (ots) - On September 09, 2019, Administrative Law Judge Cameron Elliot of the US International Trade Commission issued an Initial Determination finding that one of the bacterial strains used by Jennewein Biotechnologie to make 2'-fucosyllactose (2'-FL) infringes a patent owned by Glycosyn LLC. In the ...

more
31.05.2019 – 13:56

Zentiva
Zentiva Announces Completion of Solacium Pharma Acquisition

Prague (ots/PRNewswire) - Zentiva Group a.s. announces the completion of its previously declared acquisition of Romanian-based pharmaceutical company Solacium Pharma, together with its subsidiary, Be Well Pharma. The finalization of this acquisition will play a key role in the long-term growth strategy of Zentiva and will help to better support Romanian consumers' healthcare needs. About Zentiva Zentiva is a European ...

more
07.05.2019 – 13:12

European Association of E-Pharmacies (EAEP)

EAMSP kicks off information campaign about digitization in German healthcare sector / Fighting the allergic reaction to anything new with #neuschnupfen

more
23.11.2018 – 14:40

Zentiva
Zentiva and PHOENIX Form Strategic Partnership in Europe

Prague (ots/PRNewswire) - Zentiva and PHOENIX joined forces this week for an inaugural Annual Partnership meeting in Prague to kick off a strategic partnership between the two healthcare companies in Europe. (Logo: https://mma.prnewswire.com/media/788903/Zentiva_Logo.jpg ) "At PHOENIX group we believe that Zentiva is an excellent fit for partnering at European level, thanks to their strong heritage, broad portfolio of ...

more
22.11.2018 – 17:41

The Government of Japan
Government of Japan Showcases How Technological Innovation and Open Data Access Make Japanese Healthcare Sector Ideal for Collaboration With Germany

Munich (ots/PRNewswire) - As the world's third largest economy, Japan is leading the way for aging societies. Therefore, the Government of Japan has launched series of roundtable events across Europe highlighting the substantial opportunities for collaboration in the healthcare sector between Europe, especially ...

more
09.04.2018 – 13:00

Norgine
NHS England to Fund Endocuff Vision® for Cancer Screening Colonoscopies Bowel

Amsterdam (ots/PRNewswire) - Norgine B.V. today announced that its UK affiliate has received funding for ENDOCUFF VISION® through the NHS Innovation Technology Payment 2018/19 (ITP) scheme. The NHS ITP Programme aims to support the NHS in adopting innovation by removing financial or procurement barriers to uptake of innovative products or technologies and is a ...

more
20.02.2018 – 15:02

InSightec
Israel Ministry of Health Includes INSIGHTEC's Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services

Haifa, Israel and Miami (ots/PRNewswire) - INSIGHTEC®, a commercial-stage medical technology company revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS) announced today that the Neuravive focused ultrasound treatment will be a covered service for essential tremor patients in Israel. The ...

more
19.10.2017 – 13:32

Accuray
European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy® System

Sunnyvale, California (ots/PRNewswire) - Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accuray TomoTherapy® System by University Hospital of Tours (CHU). This most recent legal ruling marks ...

more
24.02.2016 – 01:02

Astellas Pharma Europe Limited
Britain Facing Social Care 'Time-bomb' with Thousands of People Underprepared to Look After Themselves in Old Age

Chertsey, England (ots/PRNewswire) - Experts say the knock-on effect of lack of planning for later life, as highlighted in poll conducted for this year's ASTELLAS INNOVATION DEBATE[TM],will further impact upon stretched NHS resources Results from a new survey for the annual Astellas Innovation Debate have ...

more

1